Dr. Reddy’s files 20-F annual report with US SEC for fiscal year ended March 31, 2026 – Business Upturn
Dr. Reddy's Laboratories has filed its Form 20-F annual report with the United States Securities and Exchange Commission (SEC), the company announced on May 30, 2026. The filing contains consolidated financial statements prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB) for the fiscal year ended March 31, 2026. The 20-F…
Key Insights
- This topic is currently trending
- Experts are closely monitoring developments
- It may impact future decisions
